UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:December 10,
Avenue Therapeutics (NASDAQ:ATXI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Avenue Therapeutics Charts.
Avenue Therapeutics (NASDAQ:ATXI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Avenue Therapeutics Charts.

Avenue Therapeutics, Inc. News

Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Monday 29 April 2024 (7 days ago) • GlobeNewswire Inc.
Avenue Therapeutics Announces Reverse Stock Split
Wednesday 24 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
Monday 18 March 2024 (2 months ago) • GlobeNewswire Inc.
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
Friday 15 March 2024 (2 months ago) • GlobeNewswire Inc.
Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
Monday 11 March 2024 (2 months ago) • GlobeNewswire Inc.
Form PRE 14C - Other preliminary information statements
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
Thursday 22 February 2024 (2 months ago) • GlobeNewswire Inc.
Form EFFECT - Notice of Effectiveness
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)
Form DEF 14C - Other definitive information statements
Monday 29 January 2024 (3 months ago) • Edgar (US Regulatory)
Form S-3 - Registration statement under Securities Act of 1933
Wednesday 24 January 2024 (3 months ago) • Edgar (US Regulatory)

More Avenue Therapeutics, Inc. News Articles